Unanswered Questions in the Guidelines for Antibiotic Prescription in Critically Ill Patients
Soumya S Nath, Bhagyashree
Keywords :
28-day mortality, Community acquired pneumonia, Hydrocortisone, Shock
Citation Information :
Nath SS, Bhagyashree. Unanswered Questions in the Guidelines for Antibiotic Prescription in Critically Ill Patients. Indian J Crit Care Med 2024; 28 (7):715-716.
Khilnani GC, Tiwari P, Mittal S, Kulkarni AP, Chaudhry D, Zirpe KG, et al. Guidelines for Antibiotics Prescription in Critically-ill Patients. Indian J Crit Care Med 2024. In press.
Martin-Loeches I, Torres A, Nagavci B, Aliberti S, Antonelli M, Bassetti M, et al. ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia. Intensive Care Med 2023;49(6):615–632. DOI: 10.1007/s00134-023-07033-8.
Nath SS, Nachimuthu N, Sharma D. Publisher correction: Guidelines for the management of severe community-acquired pneumonia: One confusing recommendation. Intensive Care Med 2023;49:1277. DOI: 10.1007/s00134-023-07201-w.
Saleem N, Kulkarni A, Snow TAC, Ambler G, Singer M, Arulkumaran N. Effect of corticosteroids on mortality and clinical cure in community-acquired pneumonia: A systematic review, meta-analysis, and meta-regression of randomized control trials. Chest 2023;163(3):484–497. DOI: 10.1016/j.chest.2022.08.2229.
Wan YD, Sun TW, Liu ZQ, Zhang SG, Wang LX, Kan QC. Efficacy and safety of corticosteroids for community-acquired pneumonia: A systematic review and meta-analysis. Chest 2016;149(1):209–219. DOI: 10.1378/chest.15-1733.
Dequin PF, Meziani F, Quenot JP, Kamel T, Ricard JD, Badie J, et al. CRICS-TriGGERSep network. Hydrocortisone in severe community-acquired pneumonia. N Engl J Med 2023;388(21):1931–1941. DOI: 10.1056/NEJMoa2215145.
